ангиотензин II 2 型受体过度表达在心肌梗塞发生后保持左心室功能
Zequan Yang1, Christina M Bove, Brent A French
1Department of Medicine and the Cardiovascular Research Center, University of Virginia Health System, Charlottesville 22908, USA.
Circulation
|July 3, 2002
概括
转基因小鼠中的心脏AT2-R过度表达改善了心肌梗塞后的左心室缩功能. 这表明AT2-R在心脏重塑中起着保护作用.
科学领域:
- 心血管研究研究心血管研究
- 分子心脏病学分子心脏病学
- 再生医学是一种再生医学.
背景情况:
- 血管激素II型2受体 (AT2-R) 在左心室 (LV) 重塑中的作用是刺激依赖的.
- 研究AT2-R对心肌梗塞 (MI) 后重塑的影响至关重要.
研究的目的:
- 测试心脏AT2-R过度表达减弱了心脏中风后LV重塑的假设.
- 为了评估心脏的功能和结构变化与AT2-R过度表达后MI.
主要方法:
- 心脏MRI被用来评估野生型 (WT) 和AT2-R转基因 (TG) 小鼠的LV重塑.
- 测量包括LV质量,体积,射出率和心脏病发作大小在基线和28天后的MI.
- 血液动力学参数和区域壁功能也被分析.
主要成果:
- 与WT小鼠相比,TG小鼠的基线LV功能更高.
- 在MI后的组中,心脏病的大小在后的组之间是相似的.
- 与WT小鼠相比,TG小鼠在MI后28天显著保留了LV缩功能 (更高的EF,更低的ESVI) 并改善了区域功能.
- 在28日的TG小鼠中,血压和LV dP/dt也较高.
结论:
- 心脏AT2-R过度表达显著改善了基线的LV缩功能.
- 过度表达AT2-R可以在心脏病后重塑过程中保持心脏功能.
- AT2-R可能是缓解心脏中风后不良心脏重塑的治疗目标.
更多相关视频
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798


